Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd (MDCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,296
  • Shares Outstanding, K 39,362
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,460 K
  • EBIT $ -34 M
  • EBITDA $ -34 M
  • 60-Month Beta 1.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.32
  • Most Recent Earnings $-0.82 on 03/25/26
  • Next Earnings Date 05/11/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.20
  • Number of Estimates 1
  • High Estimate $-0.20
  • Low Estimate $-0.20
  • Prior Year $-0.42
  • Growth Rate Est. (year over year) +52.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3912 +4.81%
on 04/02/26
0.5438 -24.60%
on 03/16/26
-0.1356 (-24.85%)
since 03/13/26
3-Month
0.3700 +10.81%
on 03/06/26
1.7000 -75.88%
on 03/03/26
-1.0400 (-71.72%)
since 01/13/26
52-Week
0.3700 +10.81%
on 03/06/26
8.9400 -95.41%
on 05/20/25
-3.1690 (-88.54%)
since 04/11/25

Most Recent Stories

More News
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)

The show will air as sponsored programming nationwide at 10:30 PM PST on Fox Business Network

SDST : 2.67 (+1.52%)
VTIX : 6.11 (-0.16%)
MDCX : 0.4267 (+3.07%)
YYGH : 1.5511 (+6.97%)
VVOS : 1.2499 (+3.30%)
New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms

NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX), a precision-guided biotech and life sciences company advancing innovative therapeutic platforms, has entered into...

MDCX : 0.4267 (+3.07%)
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention

PHILADELPHIA, April 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...

MDCX : 0.4267 (+3.07%)
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...

MDCX : 0.4267 (+3.07%)
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate

PHILADELPHIA, March 30, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...

MDCX : 0.4267 (+3.07%)
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

PHILADELPHIA, March 26, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...

MDCX : 0.4267 (+3.07%)
Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update

Advances Clinical Pipeline Across Dermatology, Urology, Oncology and strengthens Capital Base to support Phase 2 Programs

MDCX : 0.4267 (+3.07%)
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention.

MDCX : 0.4267 (+3.07%)
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

Phase 2 Study Demonstrated 73% clinical Clearance in the  200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADELPHIA, March...

MDCX : 0.4267 (+3.07%)
New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST

Featured Companies: FLOKI (CRYPTO:FLOKI), KLED.AI, Sagtech Global (NASDAQ:SAGT), Medicus Pharma (NASDAQ:MDCX), and YY Group (NASDAQ:YYGH)

SNYR : 0.6689 (+16.33%)
SDST : 2.67 (+1.52%)
MDCX : 0.4267 (+3.07%)
YYGH : 1.5511 (+6.97%)
NRXP : 2.27 (+2.25%)
DVLT : 0.6970 (+2.82%)
SAGT : 1.9299 (+6.04%)

Business Summary

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

See More

Key Turning Points

3rd Resistance Point 0.4788
2nd Resistance Point 0.4659
1st Resistance Point 0.4399
Last Price 0.4267
1st Support Level 0.4010
2nd Support Level 0.3881
3rd Support Level 0.3621

See More

52-Week High 8.9400
Fibonacci 61.8% 5.6663
Fibonacci 50% 4.6550
Fibonacci 38.2% 3.6437
Last Price 0.4267
52-Week Low 0.3700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.